VEGFA and neoplasm: Placental growth factor (PLGF) is a pro-angiogenic factor belonging to the VEGF family, whose overexpression has been observed in several tumor-resistant to anti-angiogenic therapies, making PLGF a potential HCC therapeutic target [102,103].